<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The transmembrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> CD98 regulates integrin signaling that in turn controls cell proliferation and survival </plain></SENT>
<SENT sid="1" pm="."><plain>CD98 expression is upregulated in various <z:mp ids='MP_0002038'>carcinomas</z:mp>, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, by generating gain- and loss-of-function mouse models featuring genetic manipulation of CD98 expression specifically in intestinal epithelial cells (IECs), we have explored the crucial role of CD98 in the regulation of intestinal homeostasis and <z:mp ids='MP_0001845'>inflammation</z:mp>-associated <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we investigated the contribution of CD98 to intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in Apc(Min/+) mice and the underlying mechanism of action </plain></SENT>
<SENT sid="4" pm="."><plain>Mice featuring IEC-specific CD98 overexpression (Tg animals) were crossed with Apc(Min/+) mice, and the characteristics of intestinal <z:mpath ids='MPATH_270'>adenoma</z:mpath> formation were assessed </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with Apc(Min/+) mice, Tg/Apc(Min/+) animals exhibited increases in both <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumor</z:e> incidence and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size; these parameters correlated with enhanced proliferation and <z:mp ids='MP_0006043'>decreased apoptosis</z:mp> of IECs </plain></SENT>
<SENT sid="6" pm="."><plain>IEC-specific CD98 overexpression resulted in increased synthesis of the oncogenic proteins c-myc and cyclin-D1 in Apc(Min/+) mice, independently of the Wnt-APC-Î²-catenin pathway, suggesting the implication of CD98 overexpression-mediated Erk activation </plain></SENT>
<SENT sid="7" pm="."><plain>IEC-specific CD98 overexpression enhanced the production of proinflammatory cytokines and chemokines that are crucial for <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>We validated our results in mice exhibiting IEC-specific CD98 downregulation (CD98(flox/+)VillinCre animals) </plain></SENT>
<SENT sid="9" pm="."><plain>IEC-specific CD98 downregulation efficiently attenuated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence and growth in Apc(Min/+) mice </plain></SENT>
<SENT sid="10" pm="."><plain>The reduction of intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> upon IEC-specific CD98 downregulation was caused by the attenuation of IEC proliferation and cytokine/chemokine production </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, we show that CD98 exerts an oncogenic activity in terms of intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, via an ability to regulate <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and survival </plain></SENT>
</text></document>